Speeches

The Dangers of Health Industry Consolidation and Corporation and the Effect on Quality, Cost and Access

The Citizens Fund Conference, Drug Industry Panel

Washington, D.C.

Date:
By: 
Christine A. Varney, Former Commissioner

The views expressed in these remarks are my own, and do not necessarily reflect those of the Federal Trade Commission or any other individual Commissioner. These comments are an abbreviated version of a longer speech given at the Annual Conference of the National Association of Retail Druggists on March 27, 1995, in Washington D.C.

I appreciate the opportunity to join you here today. I'd like to discuss some of the current changes in the pharmaceutical industry from an antitrust enforcement perspective.

Trade and the Economy: Reasserting America's Competitive Edge

The National Policy Forum Trade Megaconference on Trade and the Economy: Reasserting America's Competitive Edge

Washington, D.C.

Date:
By: 
Roscoe B. Starek, III, Former Commissioner

I appreciate very much the opportunity to speak to this distinguished audience. I plan to focus my brief remarks on the area of international antitrust cooperation. A number of recent developments have lowered some of the historic barriers to this cooperation, which I view as an important element in the evolution of free trade on a global scale.

Before I proceed, I should point out that the following remarks are my own and do not necessarily represent the views of the Federal Trade Commission or of any other Commissioner.

Pages